ID: ALA4077053

Max Phase: Preclinical

Molecular Formula: C24H44N4O2S2

Molecular Weight: 484.78

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCCCCCCCCOC(=O)Nc1cc(CNCCS)nc(CNCCS)c1

Standard InChI:  InChI=1S/C24H44N4O2S2/c1-2-3-4-5-6-7-8-9-10-11-14-30-24(29)28-21-17-22(19-25-12-15-31)27-23(18-21)20-26-13-16-32/h17-18,25-26,31-32H,2-16,19-20H2,1H3,(H,27,28,29)

Standard InChI Key:  FDEYQKLBGZUQET-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 484.78

Molecular Weight (Monoisotopic): 484.2906

AlogP: 5.59

#Rotatable Bonds: 20

Polar Surface Area: 75.28

Molecular Species: NEUTRAL

HBA: 7

HBD: 5

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 9.79

CX Basic pKa: 8.39

CX LogP: 5.42

CX LogD: 4.06

Aromatic Rings: 1

Heavy Atoms: 32

QED Weighted: 0.12

Np Likeness Score: -0.58

References

1. Tanaka A, Radwan MO, Hamasaki A, Ejima A, Obata E, Koga R, Tateishi H, Okamoto Y, Fujita M, Nakao M, Umezawa K, Tamanoi F, Otsuka M..  (2017)  A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.,  27  (16): [PMID:28666734] [10.1016/j.bmcl.2017.06.047]

2. Radwan MO, Koga R, Hida T, Ejima T, Kanemaru Y, Tateishi H, Okamoto Y, Inoue JI, Fujita M, Otsuka M..  (2019)  Minimum structural requirements for inhibitors of the zinc finger protein TRAF6.,  29  (16): [PMID:31272791] [10.1016/j.bmcl.2019.06.050]

Source

Source(1):

• Scientific Literature